Amundi increased its position in Amdocs Limited (NASDAQ:DOX – Free Report) by 46.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,962 shares of the technology company’s stock after purchasing an additional 2,540 shares during the period. Amundi’s holdings in Amdocs were worth $670,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the company. Private Trust Co. NA grew its holdings in Amdocs by 62.9% during the third quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock worth $27,000 after buying an additional 117 shares in the last quarter. Brooklyn Investment Group bought a new stake in Amdocs during the third quarter worth $28,000. Jones Financial Companies Lllp bought a new stake in Amdocs during the fourth quarter worth $36,000. SBI Securities Co. Ltd. bought a new stake in Amdocs during the fourth quarter worth $41,000. Finally, Global Retirement Partners LLC lifted its holdings in Amdocs by 45.6% during the fourth quarter. Global Retirement Partners LLC now owns 559 shares of the technology company’s stock worth $48,000 after acquiring an additional 175 shares during the period. 92.02% of the stock is currently owned by institutional investors.
Amdocs Price Performance
Shares of NASDAQ DOX opened at $89.19 on Thursday. The stock has a fifty day simple moving average of $87.00 and a two-hundred day simple moving average of $87.14. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $93.34. The firm has a market cap of $10.07 billion, a price-to-earnings ratio of 20.69, a price-to-earnings-growth ratio of 1.47 and a beta of 0.68. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22.
Amdocs Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Monday, March 31st will be issued a dividend of $0.527 per share. This is a boost from Amdocs’s previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. This represents a $2.11 dividend on an annualized basis and a yield of 2.36%. Amdocs’s payout ratio is presently 48.72%.
Analyst Ratings Changes
Separately, StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, Amdocs currently has a consensus rating of “Moderate Buy” and a consensus target price of $101.20.
Check Out Our Latest Report on Amdocs
Amdocs Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Articles
- Five stocks we like better than Amdocs
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What Are Trending Stocks? Trending Stocks Explained
- Alphabet’s Officially In A Bear Market—Time To Buy?
- 3 Best Fintech Stocks for a Portfolio Boost
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.